| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/19/2014 | EP2697207A2 Cycloalkenyl aryl derivatives for cetp inhibitor |
| 02/19/2014 | EP2697203A1 Mineralocorticoid receptor antagonists |
| 02/19/2014 | EP2697199A1 Aryl-or heteroaryl-substituted benzene compounds |
| 02/19/2014 | EP2697198A1 Substituted benzene compounds |
| 02/19/2014 | EP2696688A1 Use of substituted dithiine-dicarboximides for combating phytopathogenic fungi |
| 02/19/2014 | CN103596951A 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8h)-ones for the treatment of nervous system disorders and cancer |
| 02/19/2014 | CN103596948A Chromenone compounds as PI 3-kinase inhibitors for the treatment of cancer |
| 02/19/2014 | CN103596947A 3- or 5 - bi phenyl - 4 - ylisoxazole - based compounds useful for the treatment of fibrosis, pain, cancer and respiratory, allergic, nervous system or cardiovascular disorders |
| 02/19/2014 | CN103596946A N-(1,3,4-oxadiazol-2-yl)arylcarboxamides and use thereof as herbicides |
| 02/19/2014 | CN103596945A N-(1,2,5-oxadiazol-3-yl)-, n-(tetrazol-5-yl)- and n-(triazol-5-yl)bicycloarylcarboxamides and their use as herbicides |
| 02/19/2014 | CN103596937A 取代的苯甲酰胺衍生物 Substituted benzamide derivatives |
| 02/19/2014 | CN103596936A Herbicidally and fungicidally active 3-phneylisoxazoline-5-carboxamides and 3-phneylisoxazoline-5-thioamides |
| 02/19/2014 | CN103596929A Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators |
| 02/19/2014 | CN103596928A Neprilysin inhibitors |
| 02/19/2014 | CN103596926A Fused tricyclic compounds as RAF kinase inhibitors |
| 02/19/2014 | CN103596567A 吡唑衍生物 Pyrazole derivative |
| 02/19/2014 | CN103588766A 1,3,4-oxadiazole-containing 3-(1H-3-indolyl)-1H-pyrazole derivatives and their preparation method and use |
| 02/19/2014 | CN103588765A Synthesis method for azilsartan medoxomil or salt thereof, intermediate of azilsartan medoxomil or salt thereof and synthesis method for intermediate |
| 02/19/2014 | CN103588764A Synthesis method for azilsartan medoxomil or salt thereof and intermediate of azilsartan medoxomil or salt thereof |
| 02/19/2014 | CN103588763A 2-substituted-3-arylketone-6-(5-methyl-2-phenyl-4-ehtyoxyloxazole)benzofuran compound |
| 02/19/2014 | CN103588721A 2-(2-benzo-1,3-diazole)-2,2-difluoro-1-aryl-alcohol compound and preparation method thereof |
| 02/19/2014 | CN103588718A Novel triazinedione derivatives as GABAB receptor modulators |
| 02/19/2014 | CN103588704A Inhibitors of focal adhesion kinase |
| 02/19/2014 | CN102304125B Intermediate for preparing linezolid |
| 02/18/2014 | US8653262 CCR2 receptor antagonists and uses thereof |
| 02/18/2014 | US8653259 Process for synthesizing heterocyclic compounds |
| 02/18/2014 | US8653118 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 02/18/2014 | US8653112 Substituted pyrazoles as estrogen receptor ligands |
| 02/18/2014 | US8653081 Certain chemical entities, compositions, and methods |
| 02/18/2014 | US8653077 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 02/18/2014 | US8653074 Substituted sodium 1H-pyrazol-5-olate |
| 02/18/2014 | US8653071 α4β2 neuronal nicotinic acetylcholine receptor ligands |
| 02/18/2014 | US8653070 Hepatitis C virus inhibitors |
| 02/18/2014 | US8653069 Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia |
| 02/18/2014 | CA2701594C Heterocycle phenyl amide t-type calcium channel antagonists |
| 02/18/2014 | CA2624105C Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| 02/18/2014 | CA2577061C Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/18/2014 | CA2563831C Monocyclic heterocycles as kinase inhibitors |
| 02/13/2014 | WO2014026009A2 Inhibition of antimicrobial targets with reduced potential for resistance |
| 02/13/2014 | WO2014025976A1 Heteroaromatic compounds as bruton's tyrosine kinase (btk) inhibitors |
| 02/13/2014 | WO2014025850A1 Tricyclic amidine derivatives as hiv attachment inhibitors |
| 02/13/2014 | WO2014024752A1 5-trifluoromethyl-4-trifluoromethylsulfonyl-2-isoxazoline derivative, and method for producing same |
| 02/13/2014 | WO2014023815A1 New antibacterial compounds |
| 02/13/2014 | WO2014023754A1 Compounds for use in the treatment of disorders that are ameliorated by inhibition of hdac |
| 02/13/2014 | WO2014023723A1 Subtituted azines as pesticides |
| 02/13/2014 | WO2014023531A1 Trifluoromethylpyridine carboxamides as pesticides |
| 02/13/2014 | US20140046061 Processes Employing Cyclodextrin Derivative Quaternary Salts |
| 02/13/2014 | US20140046059 Process for the preparation of morpholino sulfonyl indole derivatives |
| 02/13/2014 | US20140046053 Neprilysin inhibitors |
| 02/13/2014 | US20140045868 Raf kinase modulator compounds and methods of use thereof |
| 02/13/2014 | US20140045860 Small molecule inhibitors for treating parasitic infections |
| 02/13/2014 | US20140045849 Pyrimidine derivatives for the treatment of viral infections |
| 02/13/2014 | US20140045848 Thiopyrimidine-based compounds and uses thereof |
| 02/13/2014 | US20140045847 Crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation |
| 02/13/2014 | US20140045844 Treatment of immune-related and inflammatory diseases |
| 02/13/2014 | US20140045838 Kinase inhibitors and method of treating cancer |
| 02/13/2014 | US20140045832 Insulin-Like Growth Factor-1 Receptor Inhibitors |
| 02/13/2014 | US20140045825 Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture |
| 02/13/2014 | US20140045823 N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof |
| 02/13/2014 | US20140045820 2,5,6,7-Tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds |
| 02/13/2014 | US20140045813 Heteroaromatic compounds as btk inhibitors |
| 02/13/2014 | US20140045802 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use |
| 02/13/2014 | US20140045800 Tetracyclic inhibitors of fatty acid amide hydrolase |
| 02/13/2014 | US20140045795 Compounds for the treatment of proliferative disorders |
| 02/13/2014 | US20140044802 Compounds useful as inhibitors of atr kinase and combination therapies thereof |
| 02/12/2014 | EP2694504A2 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8h)-ones for the treatment of nervous system disorders and cancer |
| 02/12/2014 | EP2694498A1 Aminopyrazine compounds useful as inhibitors of tra kinase |
| 02/12/2014 | EP2694497A1 Novel salts of raltegravir |
| 02/12/2014 | EP2694496A1 3- or 5 - bi phenyl - 4 - ylisoxazole - based compounds useful for the treatment of fibrosis, pain, cancer and respiratory, allergic, nervous system or cardiovascular disorders |
| 02/12/2014 | EP2694495A1 1,4-oxazepines as bace1 and/or bace2 inhibitors |
| 02/12/2014 | EP2694492A1 Novel compounds as histamine h3 receptor ligands |
| 02/12/2014 | EP2694491A1 Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 02/12/2014 | EP2694488A1 Isoxazole derivatives useful as antibacterial agents |
| 02/12/2014 | EP2694484A1 Pyrimidine derivatives for the treatment of viral infections |
| 02/12/2014 | EP2694482A1 Wnt pathway antagonists |
| 02/12/2014 | EP2694481A1 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
| 02/12/2014 | EP2694480A1 Adamantyl compounds |
| 02/12/2014 | EP2694058A2 New indolinone protein kinase inhibitors |
| 02/12/2014 | EP2693882A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 02/12/2014 | CN103582645A Diazonamide analogs |
| 02/12/2014 | CN103582637A Inhibitors of bruton's tyrosine kinase |
| 02/12/2014 | CN103582636A (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases |
| 02/12/2014 | CN103582632A 取代的苯并咪唑 Substituted benzimidazoles |
| 02/12/2014 | CN103582629A 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/2-pyrimidine-carborxamides as MGLUR5 modulators |
| 02/12/2014 | CN103570705A Substituted N-((1', 3'-azole-4'-yl)-methyl)-4-benzoyl-hexahydropyridine compound and applications thereof |
| 02/12/2014 | CN103570704A Quinazoline derivative with oxazolidinone ring side chain as well as preparation and application |
| 02/12/2014 | CN103570693A Bridged compound serving as hepatitis C inhibitor and application of bridged compound in medicines |
| 02/12/2014 | CN103570683A Multi-substituted amine compound, as well as preparation method and use thereof |
| 02/12/2014 | CN103570630A Heterocyclic nitrogen derivative and application thereof in medicines |
| 02/12/2014 | CN103570625A N-(3-aryl-heteroaryl)-4-aryl-aryl carboxamide and analog as hedgehog pathway inhibitors and application thereof |
| 02/12/2014 | CN102127065B Ortho-heterocyclic formyl substituted aniline compound as well as synthetic method and application thereof |
| 02/12/2014 | CN102015634B Pesticides |
| 02/12/2014 | CN101463031B Indazole and tetrahydrochysene indazole compounds, and preparation, pharmaceutical composition and use thereof |
| 02/11/2014 | US8648201 Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 02/11/2014 | US8648164 Low-k, flame-retardant, bi-functional benzoxazine and method for making the same |
| 02/11/2014 | US8648081 Parasiticidal dihydroisoxazole compounds |
| 02/11/2014 | US8648072 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 02/11/2014 | US8648071 Hydrazonamide compounds that modulate Hsp90 activity |
| 02/11/2014 | US8648067 Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligands |
| 02/11/2014 | CA2738563C 8-substituted isoquinoline derivatives and the use thereof |